Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Expert Review of Neurotherapeutics(1)
Journal of Psychopharmacology(1)
Neurologia(1)
Progress in Neuro-Psychopharmacology and Biological Psychiatry(1)
Origen
scopus(4)
3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility
ArticleAbstract: Kainic acid (KA) causes seizures and neuronal loss in the hippocampus. The present study investigatePalabras claves:Calbindin, Calretinin, Kainic acid, MDMA, Parvalbumin, seizuresAutores:Abad S., Antoni Camins, Auladell C., Camarasa J., Escubedo E., Junyent F., Pallás M., Pubill D.Fuentes:scopusEffects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice
ArticleAbstract: Background: 3,4-Methylenedioxymethamphetamine (MDMA) is still one of the most consumed drugs by adolPalabras claves:Alzheimer’s disease, amyloid plaques, MDMA, MEMORY, Mouse modelAutores:Abad S., Antoni Camins, Camarasa J., Escubedo E., Folch J., López-Arnau R., Pubill D., Ramon-Duaso C.Fuentes:scopusMasitinib for the treatment of mild to moderate Alzheimer's disease
ReviewAbstract: Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of dePalabras claves:ALZHÉIMER, inflammation, masitinib, Neurodegeneration, TauAutores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Lazarowski A., Miguel Marin, Olloquequi J., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusReview of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein
OtherAbstract: Introduction Alzheimer disease (AD) is a major neurodegenerative disorder which eventually results iPalabras claves:Alzheimer disease, Amyloid hypotheses, Beta-amyloid, Beta-secretase, Gamma-secretaseAutores:Abad S., Antoni Camins, Ettcheto M., Folch J., Miguel Marin, Olloquequi J., Pedros I., Petrov D.Fuentes:scopus